Valuation: Camurus AB

Market Cap 35.47B 3.63B 3.14B 2.97B 2.69B 5.05B 348B 5.09B 13.65B 176B 13.63B 13.33B 563B P/E 2026 *
37x
P/E 2027 * 24x
Enterprise Value 30.95B 3.17B 2.74B 2.59B 2.35B 4.41B 304B 4.44B 11.91B 154B 11.89B 11.63B 491B EV / Sales 2026 *
10.8x
EV / Sales 2027 * 7.91x
Free-Float
66.89%
Yield 2026 *
-
Yield 2027 * -
1 day+0.34%
1 week+0.42%
Current month+2.14%
1 month-3.48%
3 months+8.76%
6 months+27.30%
Current year-3.25%
1 week 581.5
Extreme 581.5
603
1 month 571.5
Extreme 571.5
644.5
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
714.5
3 years 290.8
Extreme 290.8
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 2002-12-31
Director of Finance/CFO 57 2025-06-30
Chief Tech/Sci/R&D Officer 58 2024-12-31
Director TitleAgeSince
Director/Board Member 63 2001-12-31
Chairman 77 2014-12-31
Director/Board Member 61 2020-05-06
Date Insider Type Main position Quantity % Market Cap. Importance
8/7/26 Sell

Executive/Senior Manager

-5,800 0.0096%
2/27/26 Sell

Chief Executive Officer

55,550 0.0928%
2/27/26 Sell

Chief Executive Officer

1,500 0.0025%
Change 5-day change 1-year change 3-year change Capi.($)
+0.34%+0.42%-13.50%+105.23% 3.63B
-0.19%+1.09%+51.85%+97.36% 1,013B
+0.33%-0.71%+50.62%+65.50% 644B
+0.49%+5.73%+20.88%+72.92% 465B
-0.22%+2.88%+38.48%+37.98% 352B
-0.07%+1.82%+16.57%+23.39% 264B
-0.31%+2.02%+6.15%+10.75% 253B
-1.53%-4.46%+36.90%+44.08% 203B
-1.60%-5.51%-22.30%-58.60% 188B
+0.49%-0.23%+30.00%+93.34% 181B
Average -0.04%-0.72%+21.56%+49.19% 356.73B
Weighted average by Cap. +0.41%+0.02%+34.47%+59.47%

Financials

2026 *2027 *
Net sales 2.86B 292M 253M 239M 217M 407M 28.03B 410M 1.1B 14.21B 1.1B 1.07B 45.33B 3.75B 383M 332M 314M 284M 534M 36.78B 538M 1.44B 18.65B 1.44B 1.41B 59.48B
Net income 949M 97.1M 84.1M 79.53M 72M 135M 9.31B 136M 365M 4.72B 365M 357M 15.06B 1.45B 149M 129M 122M 110M 207M 14.25B 208M 559M 7.23B 558M 546M 23.05B
Net Debt -4.52B -462M -400M -379M -343M -643M -44.33B -648M -1.74B -22.48B -1.74B -1.7B -71.69B -5.81B -594M -515M -487M -441M -827M -56.99B -833M -2.23B -28.9B -2.23B -2.18B -92.16B
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
316
Date Price Change Volume
26-09-15 SEK 596.00 +0.34% 55,736
26-09-14 SEK 594.00 +1.71% 48,699
26-09-11 SEK 584.00 -1.10% 49,875
26-09-10 SEK 590.50 +0.34% 44,227
26-09-09 SEK 588.50 -0.84% 70,273
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
596.00SEK
Average target price
793.00SEK
Spread / Average Target
+33.05%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMX Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!